VaxInnate reports positive results from Phase I influenza vaccine study
A total of 60 healthy young adults participated in the double-blind, dose-escalating Phase I study, which was designed to assess the safety and immunogenicity of the M2e universal
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.